MUC16 and endometrioid adenocarcinoma: The expression of miR-27a in association with cancer antigen 125 (CA-125) may be able to distinguish between healthy subjects and patients with endometrioid adenocarcinoma with an area under the curve of 0.894 (95% CI, 0.807–0.980, a sensitivity of 0.78, and a specificity of 0.97) [82].